Committed to sharing our science

Committed to sharing our science

376 results available

Understanding the Impact of Placebo on Patient-reported Health Status: An Analysis From SEQUOIA-HCM

Poster, ACC 2025

Sherrod, CF et al.

March 29, 2025
Effect of Aficamten Treatment for Up to 72 Weeks on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM and FOREST-HCM CMR Sub-studies

Poster, ACC 2025

Masri, A et al.

March 30, 2025
Evaluation of Cytochrome P450 2C9, 2C19, and 2D6 Inhibition on the Pharmacokinetics of Aficamten in Healthy Participants

Poster, ACC 2025

Maharao, N et al.

March 29, 2025
Concomitant Aficamten and Disopyramide in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Oral Presentation, ACC 2025

Masri, A et al.

March 31, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

JAMA Neurology

Shefner, JM et al

March 24, 2025